Cited by 229Renal Transplantation Outcomes and TreatmentsViral-associated cancers and disordersRenal cell carcinoma treatment

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Malignancy in Renal Transplantation

Morath, Christian, Mueller, Martina, Goldschmidt, Hartmut, Schwenger, Vedat, Opelz, Gerhard, Zeier, Martin·2004·Journal of the American Society of Nephrology

DOI 10.1097/01.asn.0000126194.77004.9b

Open this paper in CoChat — free account

Abstract

Eberhard Ritz : Feature Editor An increased incidence of malignant tumors in transplant recipients was recognized as early as in the 1970s, and this effect was ascribed to the administration of immunosuppressive medication ([1,2][1][⇓][2]). In the early days of transplantation medicine, however

Integrity signals

Registry

Crossref · 10.1097/01.asn.0000126194.77004.9b

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Guba, M. O., von Breitenbuch, P., Steinbauer, M. G. M., Koehl, G. E., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S. A., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,317
A Follow-up Study
Zacks, C. M., Abbott, R. L., & Fine, M. (1990) · Cornea · doi:10.1097/00003226-199004000-00002 · Cited by 1,240
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
Maisonneuve, P., Agodoa, L. Y. C., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., Wolf, R. A., Jones, E., Dsiney, A. P., Briggs, D., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06154-1 · Cited by 875
The Role of c-FLIP in Modulation of CD95-induced Apoptosis
Scaffidi, C., Schmitz, I., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1541 · Cited by 819
Long-term survival in renal transplant recipients with graft function
OJO, A. O., Hanson, J. A., Wolfe, R. A., Leichtman, A. B., Agodoa, L. Y. C., & Port, F. K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00816.x · Cited by 810
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
Berg, D., & Otley, C. C. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.125579 · Cited by 723
Cancer epidemiology in the last century and the next decade
Peto, J. (2001) · Nature · doi:10.1038/35077256 · Cited by 688

Show all 81 references

Sorted by citations

Evolution of the immune system in humans from infancy to old age
Simon, A. K., Hollander, G. A., & McMichael, A. (2015) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2014.3085 · Cited by 1,796
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,145
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Stallone, G., Schena, A., Infante, B., Paolo, S. D., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042831 · Cited by 982
Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Alberú, J., Pascoe, M. D., Campistol, J. M., Schena, F. P., Rial, M. D. C., Polinsky, M. S., Neylan, J. F., Korth-Bradley, J. M., Goldberg-Alberts, R., & Maller, E. S. (2011) · Transplantation · doi:10.1097/tp.0b013e3182247ae2 · Cited by 224
Malignancy after renal transplantation: the role of immunosuppression
Rama, I., & Grinyo, J. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.102 · Cited by 193
Malignancy-related mortality following kidney transplantation is common
Farrugia, D., Mahboob, S., Cheshire, J., Begaj, I., Khosla, S., Ray, D., & Sharif, A. (2013) · Kidney International · doi:10.1038/ki.2013.458 · Cited by 150
Rationale and Design of TransplantLines: A Prospective Cohort Study and Biobank of Solid Organ Transplant Recipients
Eisenga, M. F., Gomes-Neto, A. W., van Londen, M., Ziengs, A. L., Douwes, R. M., Stam, S. P., Osté, M. C. J., Knobbe, T. J., Hessels, N. R., Buunk, A. M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-024502 · Cited by 141
Malignancies in renal transplantation: an unmet medical need
Dantal, J., & Pohanka, E. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm085 · Cited by 134
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
Wagner, M., Earley, A., Webster, A. C., Schmid, C. H., Balk, E. M., & Uhlig, K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007746.pub2 · Cited by 126
Sirolimus in renal transplantation
Morath, C. P., Arns, W., Schwenger, V., Mehrabi, A., Fonouni, H., Schmidt, J., & Zeier, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm652 · Cited by 117
Self-citation
Systemic Lupus Erythematosus
Benseler, S. M., & Silverman, E. D. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.01.010 · Cited by 118
Viral-Associated Nonmelanoma Skin Cancers: A Review
Dubina, M., & Goldenberg, G. (2009) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3181a58234 · Cited by 111
Management of solid tumours in organ-transplant recipients
Ajithkumar, T., Parkinson, C., Butler, A. J., & Hatcher, H. M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70315-7 · Cited by 111
Anal cancer in renal transplant patients
Patel, H., Silver, A. R., & Northover, J. M. A. (2005) · International Journal of Colorectal Disease · doi:10.1007/s00384-005-0023-3 · Cited by 109
Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
Djamali, A., Samaniego, M., Muth, B. L., Muehrer, R. J., Hofmann, R. M., Pirsch, J. D., Howard, A., Mourad, G., & Becker, B. N. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01371005 · Cited by 99
Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors
Pascual, J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm088 · Cited by 98
Minimally Invasive Approach to the Repair of Injured Skeletal Muscle With a Shape-memory Scaffold
Wang, L., Cao, L., Shansky, J., Wang, Z., Mooney, D. J., & Vandenburgh, H. H. (2014) · Molecular Therapy · doi:10.1038/mt.2014.78 · Cited by 96
Imaging of Renal Transplant Complications throughout the Life of the Allograft: Comprehensive Multimodality Review
Sugi, M. D., Joshi, G., Maddu, K. K., Dahiya, N., & Menias, C. O. (2019) · Radiographics · doi:10.1148/rg.2019190096 · Cited by 91
Common viral infections in kidney transplant recipients
Vanichanan, J., Udomkarnjananun, S., Avihingsanon, Y., & Jutivorakool, K. (2018) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.18.0063 · Cited by 88
Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History
Brattström, C., Granath, F. N., Edgren, G., Smedby, K. E. E., & Wilczek, H. (2013) · Transplantation · doi:10.1097/tp.0b013e31829854b7 · Cited by 86
A 30-Year Analysis of Colorectal Adenocarcinoma in Transplant Recipients and Proposal for Altered Screening
Johnson, E. E., LEVERSON, G. E., Pirsch, J. D., & Heise, C. P. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0084-4 · Cited by 80
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance
Campistol, J. M., Albanell, J., Arns, W., Boletis, I., Dantal, J., de Fijter, J. W., Mortensen, S., Neumayer, H. ‐., Øyen, O. M., Pascual, J., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm090 · Cited by 76
Reduction of Immunosuppression for Transplant-Associated Skin Cancer
Otley, C. C., & Maragh, S. L. H. (2005) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31038 · Cited by 84
Cancer Immunoediting: From Immune Surveillance to Immune Escape
Kim, R. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50066-3 · Cited by 74
Therapeutic Management of De Novo Urological Malignancy in Renal Transplant Recipients: The Experience of the French Department of Urology and Kidney Transplantation from Bordeaux
Elkentaoui, H., Robert, G., Pasticier, G., Bernhard, J., Couzi, L., Merville, P., Ravaud, A., Ballanger, P., Ferrière, J.-M., & Wallerand, H. (2009) · Urology · doi:10.1016/j.urology.2009.06.106 · Cited by 72
The long-term outcomes of systemic vasculitis
Westman, K. W. A., Floßmann, O., & Gregorini, G. A. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu392 · Cited by 65
Minimization of Maintenance Immunosuppression Early After Renal Transplantation: An Interim Analysis
Bemelman, F. J., de Maar, E. F., Press, R. R., van Kan, H. J. M., ten Berge, I. J. M., van der Heide, J. J. H., & de Fijter, H. W. (2009) · Transplantation · doi:10.1097/tp.0b013e3181af1df6 · Cited by 62
Cancer after renal transplantation
Vasudev, B. S., & Hariharan, S. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f06bba · Cited by 60
The Oncogene ATF3 Is Potentiated by Cyclosporine A and Ultraviolet Light A
Dziunycz, P., Lefort, K., Wu, X., Freiberger, S. N., Neu, J., Djerbi, N., Iotzova-Weiss, G., French, L. E., Dotto, G. P., & Hofbauer, G. F. L. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.77 · Cited by 53
Increased Incidence of Colorectal Malignancies in Renal Transplant Recipients: A Case Control Study
Park, J. M., Choi, M., Kim, S. W., Chung, I. ‐., Yang, C. W., Kim, Y. S., Jung, C. K., Lee, K., & Kang, J. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03231.x · Cited by 50
Calcineurin Inhibitors Modulate CXCR3 Splice Variant Expression and Mediate Renal Cancer Progression
Datta, D. B., Contreras, A. G., Grimm, M. R., Waaga-Gasser, A. M., Briscoe, D. M., & Pal, S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008040394 · Cited by 51
Long‐term outcome of antineutrophil cytoplasmic antibody‐associated small vessel vasculitis after renal transplantation
Marco, H., Mirapeix, E., Arcos, E., Comas, J., Ara, J., Gil‐Vernet, S., Puig, J. M., Vinyas, O., Perelló, M., Oppenheimer, F., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12084 · Cited by 48
Post renal-transplant malignancy surveillance
Manickavasagar, R., & Thuraisingham, R. C. (2020) · Clinical Medicine · doi:10.7861/clinmed.2019-0423 · Cited by 47
Pharmacodynamic monitoring of calcineurin inhibitor therapy: Is there a clinical benefit?
Sommerer, C., Giese, T., Meuer, S. C., & Zeier, M. G. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn556 · Cited by 46
Self-citation
Pharmacodynamic immune monitoring of NFAT‐regulated genes predicts skin cancer in elderly long‐term renal transplant recipients
Sommerer, C., Hartschuh, W., Enk, A., Meuer, S. C., Zeier, M. G., & Giese, T. (2008) · Clinical Transplantation · doi:10.1111/j.1399-0012.2008.00819.x · Cited by 45
Self-citation
Calcineurin inhibitors and NFAT-regulated gene expression
Sommerer, C., Meuer, S. C., Zeier, M. G., & Giese, T. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.09.041 · Cited by 44
Self-citation
Cancer in Patients on Chronic Dialysis in Korea
Lee, J. E., Han, S. H., Cho, B. C., Park, J. T., Yoo, T., Kim, B. S., Park, H. C., Kang, S., Lee, H. Y., Han, D. S., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.s1.s95 · Cited by 44
Malignancies of the colorectum and anus in solid organ recipients
Aigner, F., Boeckle, E., Albright, J. B., Kilo, J., Boesmueller, C., Conrad, F., Wiesmayr, S., Antretter, H., Margreiter, R., Mark, W., et al. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00469.x · Cited by 41
Posttransplant Epstein-Barr Virus-Associated Myogenic Tumors: Case Report and Review of the Literature
Sprangers, B., Smets, S., Sagaert, X., Woźniak, A., Wollants, E., Ranst, M. A. V., Dêbiec‐Rychter, M., Sciot, R., Vanrenterghem, Y. F. C., & Kuypers, D. R. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02054.x · Cited by 41
Is There a Role for Proliferation Signal/mTOR Inhibitors in the Prevention and Treatment of De Novo Malignancies After Heart Transplantation? Lessons Learned From Renal Transplantation and Oncology
Valantine, H. A. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.03.010 · Cited by 40
Renal Cell Carcinoma of Native Kidney After Renal Transplantation: Clinical Relevance of Early Detection
Filocamo, M. T., Zanazzi, M., Marzi, V. L., Guidoni, L. R. M., Villari, D., Dattolo, E., & Nicita, G. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.08.082 · Cited by 37
Transmission of Malignancy with Solid Organ Transplants
Morath, C. P., Schwenger, V., Schmidt, J., & Zeier, M. G. (2005) · Transplantation · doi:10.1097/01.tp.0000186911.54901.21 · Cited by 37
Self-citation
Skin cancer in renal allograft recipients – experience in different ethnic groups residing in the same geographical region
Moosa, M. R., & Gralla, J. (2005) · Clinical Transplantation · doi:10.1111/j.1399-0012.2005.00413.x · Cited by 36
De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997–2012
Mazzucotelli, V., Piselli, P., Verdirosi, D., Cimaglia, C., Cancarini, G. C., Serraino, D., & Sandrini, S. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0385-y · Cited by 35
Influence of Current and Previous Smoking on Cancer and Mortality After Kidney Transplantation
Opelz, G., & Döhler, B. (2015) · Transplantation · doi:10.1097/tp.0000000000000804 · Cited by 34
Self-citation
Immunosuppressant-Driven De Novo Malignant Neoplasms after Solid-Organ Transplant
Billups, K. L., Neal, J. M., & Salyer, J. (2015) · Progress in Transplantation · doi:10.7182/pit2015826 · Cited by 34
Cumulative cancer incidence and mortality after kidney transplantation in Japan: A long‐term multicenter cohort study
Imamura, R., Nakazawa, S., Yamanaka, K., Kakuta, Y., Tsutahara, K., Taniguchi, A., Kawamura, M., Kato, T., Abe, T., Uemura, M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3636 · Cited by 32
Aftercare for Patients with Transplanted Organs
Schrem, H., Barg‐Hock, H., Strassburg, C. P., Schwarz, A., & Klempnauer, J. L. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0148 · Cited by 34
High-Resolution Anoscopy in the Diagnosis of Anal Cancer Precursor Lesions in Renal Graft Recipients
Silva, I. T. D. C. E., Ferreira, L. C. D. L., Gimenez, F. S., Guimarães, R. A. G., Fujimoto, L. B. M., Cabral, C. R. B., Mozzer, R. V., & Atala, L. D. S. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9750-8 · Cited by 31
The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancy
Geissler, E. K. (2013) · Transplantation Research · doi:10.1186/2047-1440-2-s1-s2 · Cited by 31
Is Kidney Transplantation a Better State of CKD? Impact on Diagnosis and Management
Parajuli, S., Clark, D. F., & Djamali, A. (2016) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.09.006 · Cited by 30
Clinical Insights for Cancer Outcomes in Renal Transplant Patients
Alberú, J. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.07.006 · Cited by 31
Waiting Time for Patients with History of Malignant Disease before Listing for Organ Transplantation
Girndt, M., & Köhler, H. (2005) · Transplantation · doi:10.1097/01.tp.0000187112.81714.26 · Cited by 30
SYSTEMIC LUPUS ERYTHEMATOSUS
Silverman, E. D., & Eddy, A. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10021-4 · Cited by 29
Adenomatoid tumour of the uterus is frequently associated with iatrogenic immunosuppression
Tamura, D., Maeda, D., Halimi, S. A., Okimura, M., Kudo‐Asabe, Y., Ito, S., Sato, N., Shibahara, J., Nanjo, H., Terada, Y., et al. (2018) · Histopathology · doi:10.1111/his.13726 · Cited by 27
Gender differences in cancer risk after kidney transplantation
Buxeda, A., Redondo‐Pachón, D., Pérez‐Sáez, M. J., Bartolomé-Solanas, Á., Mir, M., Pascual‐Dapena, A., Sans, A., Durán, X., Crespo, M., & Pascual, J. (2019) · Oncotarget · doi:10.18632/oncotarget.26859 · Cited by 28
Incidence and Long-Term Prognosis of Cancer After Kidney Transplantation
de Mier, M. V. P.-R., Cabello, M. D. N., Martínez-Vaquera, S., López-Andréu, M., Agüera, M. L., Rodríguez‐Benot, A., & García, P. A. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.08.043 · Cited by 26
Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
Asleh, R., Alnsasra, H., Habermann, T. M., Briasoulis, Α., & Kushwaha, S. S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.787975 · Cited by 25
Management of localized prostate cancer by retropubic radical prostatectomy in patients after renal transplantation
Hoda, M. R., Hamza, A., Greco, F., Wagner, S., Reichelt, O., Heynemann, H., Fischer, K., & Fornara, P. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq193 · Cited by 25
Post-renal transplant malignancies: Opportunities for prevention and early screening
Turshudzhyan, A. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100283 · Cited by 26
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Kirby, S., Satoskar, A. A., Brodsky, S. V., Pope‐Harman, A., Nunley, D. R., Hitchcock, C. L., Pelletier, R. P., Ross, P., Nádasdy, T., & Shilo, K. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-25 · Cited by 24
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term
Fuhrmann, J. D., Valkova, K., Moos, S. C. V., Wuthrich, R. P., Müller, T., & Schachtner, T. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac013 · Cited by 25
Renal Cell Carcinoma in Kidney Transplant Recipients and Dialysis Patients
Lee, H. H., Choi, K. H., Yang, S. C., & Han, W. K. (2012) · Korean journal of urology · doi:10.4111/kju.2012.53.4.229 · Cited by 23
Amelioration of Acute Renal Failure by Stem Cell Therapy—Paracrine Secretion Versus Transdifferentiation into Resident Cells
Togel, F. E., Hu, Z., Weiss, K., Isaac, J., Lange, C., & Westenfelder, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030294 · Cited by 23
Renal Transplantation
Kim, P. Y., Shoghi, A., & Fananapazir, G. (2023) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2023.04.004 · Cited by 22
Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
Basu, A., Banerjee, P., Contreras, A. G., Flynn, E. A., & Pal, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023919 · Cited by 22
Antineoplastic effects of mammalian target of rapamycine inhibitors
Salvadori, M. (2012) · World Journal of Transplantation · doi:10.5500/wjt.v2.i5.74 · Cited by 23
Bladder Cancer in Renal Allograft Recipients: Risk Factors and Outcomes
Medani, S., O’Kelly, P., O'Brien, K. M., Mohan, P., Magee, C., & Conlon, P. J. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.06.075 · Cited by 22
Strategies for reducing the renal transplant waiting list: a review.
Shrestha, B. M. (2009) · PubMed · Cited by 22
De Novo Urologic Malignancies in Renal Transplant Recipients
Antunes, H. P., Tavares-da-Silva, E., Oliveira, R. C., Carvalho, J., Parada, B., Bastos, C., & Figueiredo, A. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.02.086 · Cited by 22
Renal Cell Carcinoma in the Allograft: What Is the Role of Polyomavirus
Neirynck, V., Claes, K. J., Naesens, M., Wever, L. D., Pirenne, J., Kuypers, D. R. J., Vanrenterghem, Y. F. C., Poppel, H. V., Kabanda, A., & Lerut, E. (2012) · Case Reports in Nephrology and Urology · doi:10.1159/000341917 · Cited by 22
Avoiding Pitfalls: What an Endoscopist Should Know in Liver Transplantation—Part II
Sharma, S., Gurakar, A. O., Camcı, C., & Jabbour, N. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0520-7 · Cited by 22
Incidence of Malignancy after Living Kidney Transplantation: A Multicenter Study from Iran
Einollahi, B., Rostami, Z., Nourbala, M. H., Lessan‐Pezeshki, M., Simforoosh, N., Nemati, E., Pourfarziani, V., Beiraghdar, F., Nafar, M., Pour-Reza-Gholi, F., et al. (2012) · Journal of Cancer · doi:10.7150/jca.3042 · Cited by 22
Monitoring immunosuppression with measures of NFAT decreases cancer incidence
Giese, T., Sommerer, C., Zeier, M. G., & Meuer, S. C. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.520 · Cited by 21
Self-citation
Cancer in patients on dialysis and after renal transplantation
Fischereder, M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn183 · Cited by 21
Primary Care of the Renal Transplant Patient
Gupta, G., Unruh, M. L., Nolin, T. D., & Hasley, P. B. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1354-5 · Cited by 21
Malignancy in Kidney Transplantation: A 25-Year Single-center Experience in Portugal
Aguiar, B., Amorim, T. S., Romãozinho, C., Santos, L., Macario, F. J. G. R. M., Alves, R., Campos, M., & Mota, A. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.03.039 · Cited by 20
Calcineurin inhibitors in HLA-identical living related donor kidney transplantation
Verghese, P. S., Dunn, T. B., Chinnakotla, S., Gillingham, K. J., Matas, A. J., & Mauer, M. S. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft447 · Cited by 20
Comparison of Peritoneal Dialysis and Hemodialysis After Kidney Transplant Failure
Kang, G., Jang, M. J., Hwang, E., Park, S. B., & Han, S. Y. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.08.035 · Cited by 17
Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40
Dubina, M., & Goldenberg, G. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.01.023 · Cited by 17
Recipient Criteria Predictive of Graft Failure in Kidney Transplantation
Alex, A., Rosen, L. M., Alexander, M., Nicastro, J. M., Yang, J., Siskind, E. J., Alex, L., Sameyah, E., Bhaskaran, M. C., Ali, N. M., et al. (2015) · International Journal of Angiology · doi:10.1055/s-0035-1563605 · Cited by 16
Occurrence and regression of BK polyomavirus associated carcinoma: a clinical and next-generation sequencing study
Fu, F., Deng, W.-F., Yu, S., Liu, Y., Li-xin, Y., Liu, R., Lang, J., Geng, D., Geng, J., Li, J., et al. (2018) · Clinical Science · doi:10.1042/cs20180443 · Cited by 15
Incidental neoplasms in renal biopsies
Pankhurst, T., Howie, A. J., Adu, D., Wallace, D. M. A., & Lipkin, G. W. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi149 · Cited by 15
Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients
Piana, A., Andraș, I., Diana, P., Verri, P., Gallioli, A., Campi, R., Prudhomme, T., Hevia, V., Boissier, R., Breda, A., et al. (2022) · Asian journal of urology · doi:10.1016/j.ajur.2022.06.001 · Cited by 14
Renal Cancer in Recipients of Kidney Transplant
Dhakal, P., Giri, S., Siwakoti, K., Rayamajhi, S., & Bhatt, V. R. (2016) · Rare Tumors · doi:10.4081/rt.2017.6550 · Cited by 14
The Role of Microscopic Hematuria in the Evaluation of Urologic Malignancy in Renal Transplant Recipients
Kim, D. Y., Abouljoud, M. S., & Parasuraman, R. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.01.072 · Cited by 14
Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience
Žilinská, Z., Sersenová, M., Chrastina, M., Breza, J., Jr., Beňa, Ľ., Baltesová, T., Jurčina, A., Roland, R., LACKOVA, E., Čellár, M., et al. (2017) · Neoplasma · doi:10.4149/neo_2017_220 · Cited by 14
Immunotherapy for De Novo Renal Transplantation
Junior, H. T. S., Machado, P. P., Felipe, C. R., & Pestana, J. O. M. (2006) · Drugs · doi:10.2165/00003495-200666130-00002 · Cited by 14
Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient
Gheith, O. A. A., Bakr, M. A., Wafa, E. W., Fouda, A. E., Agroudy, A. E. E., Refaie, A. F., Donia, A. F., Sabry, A. A.-A., Sobh, M. A. K., Shokeir, A. A., et al. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0470-y · Cited by 13
Outcome of Patients With Small Vessel Vasculitis After Renal Transplantation: National Database Analysis
El-Husseini, A. A., Saleh, S., Hamad, O., Mei, X., Castellanos, A. L., Davenport, D. L., Gedaly, R., & Sawaya, B. P. (2018) · Transplantation Direct · doi:10.1097/txd.0000000000000769 · Cited by 13
De novo multifocal renal cell carcinoma in the renal allograft
Alexander, M. P., Farag, Y. M. K., Mittal, B. V., Rennke, H. G., Tullius, S. G., & Singh, A. K. (2008) · Kidney International · doi:10.1038/ki.2008.228 · Cited by 13
Postrenal transplant malignancy: Incidence, risk factors, and prognosis
Elserwy, N., Lotfy, E., Fouda, M., Mahmoud, M. I., Donia, A. F., Mashaly, M. E., Abbas, M. H., Abuelmagd, M. M., Abouelenein, R., Ismail, M. I., et al. (2017) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.206456 · Cited by 13
Comparison of Patient Outcome According to Renal Replacement Modality after Renal Allograft Failure
Chung, B. H., Lee, J. Y., Kang, S. H., Sun, I. O., Choi, S. R., Park, H. S., Kim, J. I., Moon, I. S., Shin, Y. S., Park, J. H., et al. (2011) · Renal Failure · doi:10.3109/0886022x.2011.559678 · Cited by 13
Cancer Screening in End-Stage Kidney Disease
Shirazian, S., Starakiewicz, P., & Latcha, S. (2021) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2021.09.006 · Cited by 12
Posttransplant Malignancies in Renal Transplant Recipients: 22-years Experience from a Single Center in Pakistan
Yunus, M., Aziz, T., & Mubarak, M. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.575 · Cited by 12
Mortality risk after cancer diagnosis in kidney transplant recipients: the limitations of analyzing hospital administration data alone
Jackson‐Spence, F., Gillott, H., Tahir, S., Nath, J., Mytton, J., Evison, F., & Sharif, A. (2018) · Cancer Medicine · doi:10.1002/cam4.1367 · Cited by 12
Three‐year follow‐up of malignancies in tacrolimus‐treated renal recipients – an analysis of European multicentre studies
Cowlrick, I., Delventhal, H., Kaipainen, K., Krcmar, C. R., Petan, J. A., & Schleibner, S. (2008) · Clinical Transplantation · doi:10.1111/j.1399-0012.2008.00796.x · Cited by 12
Antithymocyte Globulin Induction Therapy in Heart Transplantation: Prospective Randomized Study of High vs Standard Dosage
Faggian, G. G., Forni, A., Milano, A. D., Chiominto, B., Walpoth, B. H., Scarabelli, T. M., & Mazzucco, A. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.06.036 · Cited by 11
Approaches towards Individualized Immune Intervention
Giese, T., Sommerer, C., Zeier, M. G., & Meuer, S. C. (2010) · Digestive Diseases · doi:10.1159/000282063 · Cited by 11
Self-citation
Association of bladder adenocarcinoma and BK virus infection in a pancreatico-renal transplant recipient
Rivera, C. F., Hernández, Á. A., Reboredo, J. M., & Gómez, I. R. (2010) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfq042 · Cited by 11

Authors: Morath, C., Mueller, M., Goldschmidt, H., Schwenger, V., Opelz, G., & Zeier, M.
Affiliations: Heidelberg University (DE)
ORCID: Morath, Christian
Mueller, Martina
Goldschmidt, Hartmut
Schwenger, Vedat
Zeier, Martin
Venue: Journal of the American Society of Nephrology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-06
Volume: 15
Issue: 6
Pages: 1582-1588
ISSN: 1046-6673 (ISSN-L)
DOI: 10.1097/01.asn.0000126194.77004.9b
OpenAlex: W2142862239
Cited by: 229
References: 81
Citations by year: 2026: 1 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 9 · 2019: 9 · 2018: 13 · 2017: 10 · 2016: 9 · 2015: 14 · 2014: 10 · 2013: 9 · 2012: 17
FWCI: 9.06
Type: journal article
Language: en
Open access: closed
Locations: Journal of the American Society of Nephrology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Keywords: kidney transplantation, cancer, immunosuppressive therapy
MeSH terms: Humans, Immunosuppressive Agents, Kidney Neoplasms, Postoperative Complications, Virus Diseases, Kidney Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Malignancy in Renal Transplantation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks